V2 Financial group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,300
Closed -$201K 87
2025
Q1
$201K Buy
+3,300
New +$192K 0.13% 81
2024
Q4
Sell
-4,500
Closed -$233K 82
2024
Q3
$233K Hold
4,500
0.15% 70
2024
Q2
$220K Buy
+4,500
New +$201K 0.15% 72

Other funds holding BMY

V2 Financial group's BMY Position: Q2 2025 in Review

V2 Financial group sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 3,300 shares — an estimated $201K sold.

V2 Financial group first reported a position in BMY in Q2 2024 and held it in 3 quarters. The position peaked at $233K in Q3 2024. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • V2 Financial group reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • V2 Financial group sold 3,300 Bristol-Myers Squibb shares in Q2 2025, an estimated $201K.
  • V2 Financial group first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 3 quarters.
  • V2 Financial group's Bristol-Myers Squibb position peaked at $233K in Q3 2024.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on V2 Financial group's 13F filing for Q2 2025, filed 18 Aug 2025.